BREAKING NEWS...

Article

The black eye the FDA received recently over its handling of Vioxx (rofecoxib, Merck) and antidepressants hasn't slowed the agency's new drug approval rate for 2004. It cleared 31 new molecular entities (NMEs) last year, up from 21 in 2003.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.